Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its

- Marked increases in overall survival observed across soft tissue sarcoma patients - - Demonstrated improvement of median progression free survival in...

Related Keywords

Chicago , Illinois , United States , William Duke , Xiaodong Yang , Bruce Mackle , Apexigen Inc , Columbia University , Securities Exchange , Nasdaq , Chief Executive Officer , Securities Act , Securities Exchange Act , Nasdaq Apgn , Apexigen ,